EEG Biofeedback in the Treatment of Chronic Treatment-Resistant PTSD
Application of Neurofeedback as a Mechanism of Affect Regulation Treatment of Adults With Complex Adaptation to Chronic Interpersonal Trauma Exposure
1 other identifier
interventional
52
1 country
1
Brief Summary
The purpose of this study is to determine whether neurofeedback (NF) training can significantly reduce the symptoms of Posttraumatic Stress Disorder (PTSD) in individuals with significant affect dysregulation and chronic, treatment-resistant PTSD. The primary aims of this study include:
- 1.To examine whether NF has the potential to significantly reduce symptoms of PTSD.
- 2.To examine whether NF training can specifically target the area of affect regulation.
- 3.To examine the mechanism of NF through elucidating the relationship between affect regulation and PTSD symptom change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 13, 2010
CompletedFirst Posted
Study publicly available on registry
December 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedAugust 15, 2019
June 1, 2011
3 years
December 13, 2010
August 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Clinician Administered PTSD Scale Score
The CAPS is considered the gold standard for the assessment of PTSD (National Center for PTSD Research). It is a clinician administered 30-item interview that corresponds to DSM-IV criteria for PTSD. Each item of the CAPS has two parts, frequency and intensity, which are both scored on a 5-point scale from 0 to 4. A general cut-off rule of frequency greater than or equal to 1 and intensity greater than or equal to 2 for a symptom to count towards diagnosis will be employed in assigning PTSD diagnosis.
Participants are assessed at baseline (prior to beginning training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)
Secondary Outcomes (2)
Change in Davidson Trauma Scale Score
Participants are assessed at baseline (prior to beginning training), every 4 weeks (corresponding to 8 sessions of training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)
Change in Inventory of Altered Self-Capacities Score
Participants are assessed at baseline (prior to beginning training), every 4 weeks (corresponding to 8 sessions of training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)
Study Arms (2)
Neurofeedback T4-P4
EXPERIMENTAL40 sessions of SMR neurofeedback training using T4-P4 placement administered twice weekly
Neurofeedback T3-T4
ACTIVE COMPARATOR40 sessions of SMR neurofeedback using T3-T4 placement training administered twice weekly
Interventions
Operant conditioning of the EEG provided by computer reinforcement.
Eligibility Criteria
You may qualify if:
- CAPS score of 60 or over
- t-score of 70 or over on the affect dysregulation subscale of the IASC; AND
- Treatment-unresponsiveness as defined by having had at least 3 years of prior treatment focused on dealing with the consequences of the index trauma, or having been in treatment with more than three providers during the preceding decade
You may not qualify if:
- Serious non-stable medical illness
- GAF \< 40
- Bipolar disorder, obsessive-compulsive disorder (OCD), schizophrenia, and other psychotic disorder, or documented organic impairment
- Active suicidal risk, self-injury or physical aggression toward others within the past year
- Substance dependence or abuse in the past 6 months, as defined by DSM IV criteria
- Individuals taking a benzodiazepine more than twice per week (non-response seen in pilot work) AND
- Any other condition that might interfere with the person's capacity to give informed consent, or to adhere to the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Trauma Center at JRI
Brookline, Massachusetts, 02446, United States
Related Publications (1)
Gapen M, van der Kolk BA, Hamlin E, Hirshberg L, Suvak M, Spinazzola J. A Pilot Study of Neurofeedback for Chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5.
PMID: 26782083BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bessel van der Kolk, M.D.
Justice Resource Institute
- STUDY DIRECTOR
Mark Gapen, Ph.D.
Justice Resource Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2010
First Posted
December 14, 2010
Study Start
December 1, 2009
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 15, 2019
Record last verified: 2011-06